WO2006056098A1 - The process for resolving dl-epherine, pseudoephedrine or the derivatives thereof and the resolving agents - Google Patents

The process for resolving dl-epherine, pseudoephedrine or the derivatives thereof and the resolving agents Download PDF

Info

Publication number
WO2006056098A1
WO2006056098A1 PCT/CN2004/001338 CN2004001338W WO2006056098A1 WO 2006056098 A1 WO2006056098 A1 WO 2006056098A1 CN 2004001338 W CN2004001338 W CN 2004001338W WO 2006056098 A1 WO2006056098 A1 WO 2006056098A1
Authority
WO
WIPO (PCT)
Prior art keywords
derivative
ephedrine
formula
tartaric acid
resolving agent
Prior art date
Application number
PCT/CN2004/001338
Other languages
French (fr)
Chinese (zh)
Inventor
Song Li
Aihua Nie
Original Assignee
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China filed Critical Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
Priority to PCT/CN2004/001338 priority Critical patent/WO2006056098A1/en
Publication of WO2006056098A1 publication Critical patent/WO2006056098A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton

Definitions

  • the present invention relates to a D-(+)- or L-(-)-tartaric acid or a derivative thereof as a resolving agent for DL-ephedrine or a derivative thereof and a method for its resolution.
  • the invention also relates to a recovery method for a resolving agent. Background technique
  • ephedrine 1-phenyl-2-methylamino-1-propanol. Since the 1- and 2-positions are chiral carbon atoms, there are four isomers of this kind of compound, namely D-(-)- Ephedrine (natural) and L- ( + ) - ephedrine (non-natural) and L- ( + ) - pseudoephedrine (natural) and D- ( - ) - pseudoephedrine (non-natural), the structure is as follows:
  • ephedra Because the main producing area of growing ephedra is the most serious desertification in China, and ephedra is the main sand fixing plant in these areas; therefore, the excessive excavation of ephedra has caused serious impact on the ecological environment of these areas in recent years. . Therefore, the production of ephedrine that meets market requirements by chemical synthesis will be an effective way to reduce the extraction of ephedra, protect the ecological environment, and meet market demand. At present, the main problem faced by chemical synthesis in the production of ephedrine is how to obtain optically pure products at low cost; although the method of asymmetric synthesis has been greatly developed, there are not many methods of industrial value.
  • L-(+)-mandelic acid and D-(-)-mandelic acid are resolving agents (a), US Patent: 1867274; b), J, Am. Chem. Soc., 1929, 51: 1906. ): The advantage of this method is that the resolution is high (more than 75%); the optical purity of the product is high (more than 99%). Disadvantages are: L-(+)-mandelic acid and D-(-)-mandelic acid are not easily available, and the price is high, which cannot meet the requirements of large industrial production.
  • L-(+)-tartaric acid is a resolving agent: Natural L-(+)-tartaric acid is a great repellent because its price is cheap so that people can ignore it. If L-(+)-tartaric acid can be used to separate DL-ephedrine, it will be an industrially valuable method.
  • There are many articles (a), UK Patent: 354975, 356931; b), Ger. Patent: DE549970; c), J. Pharm. Soc. Japan, 1927, 47: 109. ) Trying to use L-(+) - a method for the resolution of DL-ephedrine or a derivative thereof by tartaric acid, but there is also literature (J, Am, Chem. Soc, 1929, 51: 1906.) which proves that this method cannot successfully resolve DL-ephedrine or its derivative .
  • the present inventors have found through research that the following formula (I) D-(+)- or L-(-)-tartaric acid or a derivative thereof exhibits an excellent effect in the resolution of ephedrine or a derivative thereof, thereby The industrial production of optically active ephedrine or its derivatives and environmental protection provides a strong guarantee.
  • one aspect of the present invention relates to D-(+)- or L-(-)-tartaric acid or a derivative thereof represented by the formula (I) as a resolving agent for the resolution of DL-ephedrine or a derivative thereof:
  • DL-ephedrine or a derivative thereof as used in the present invention means DL-ephedrine or a derivative thereof of the formula (II), or DL-pseudoephedrine or a derivative thereof of the formula (III):
  • R 2 is each independently H, Ci Cs linear or branched alkyl, and R 3 and R 4 are each independently ⁇ , ⁇ , ⁇ 3 ⁇ 4, N0 2 or a linear or branched alkyl group, ⁇ 3 linear or branched alkoxy groups,
  • R and R 2 are each independently H, d to C 5 linear or branched alkyl
  • R 3 , and R 4 are each independently H, OH, halogen, N0 2 or d ⁇ C. 3 straight or branched alkyl, straight or branched alkoxy.
  • the D- or L-configuration tartaric acid derivative of the above formula (I) is used as a resolving agent for DL-ephedrine or a derivative thereof.
  • the D- or L-configuration tartaric acid derivative of the above formula (I) is used as the DL-ephedrine of the formula (II) or a derivative thereof or the DL-pseudoephedrine of the formula (III) or Resolving agent for derivatives.
  • tartaric acid of the D- or L-configuration as shown in formula (IV) is used as a resolving agent for DL-ephedrine or a derivative thereof:
  • tartaric acid of the D- or L-configuration as shown in the above formula (IV) is used as the DL-ephedrine of the formula (II) or a derivative thereof or the DL-pseudoephedrine of the formula (III) Resolving agent for its or its derivatives:
  • tartaric acid represented by the above formula (IV) is used as a resolving agent for the formula (V) DL-ephedrine:
  • Another aspect of the invention relates to a method for the resolution of DL-ephedrine or a derivative thereof, which comprises the D-(+)- or L-(-)-tartaric acid derivative represented by formula (I) and DL-ephedra
  • the alkali or a derivative thereof is contacted at a certain molar ratio, and is subjected to a conventional treatment to obtain a crystal in which DL-ephedrine or a derivative thereof is combined with a resolving agent, and the obtained crystal is acidified to obtain an optically active ephedrine or a derivative thereof.
  • Structure
  • inventions refers to the addition of QrC 4 lower aliphatic alcohol to a mixture of DL-ephedrine or a derivative thereof and a resolving agent, to completely dissolve it, at 50 to 70 ° C, and An equal volume of alcohol, water of the same temperature, stirred for 20-60 minutes, allowed to stand at room temperature overnight, the solid was filtered off and the mother liquid was recovered, and the solid was washed with acetone or diethyl ether and dried.
  • the term "acidification treatment" as used in the present invention refers to the addition of 0.5 N to 2.5 N of an appropriate amount of a mineral acid such as dilute hydrochloric acid to the crystal of the conjugate of the obtained DL-ephedrine or a derivative thereof and the resolving agent, at 20 -
  • a mineral acid such as dilute hydrochloric acid
  • the mixture was completely dissolved by stirring at 40 ° C, extracted twice with an organic solvent, and the aqueous layer was evaporated under reduced pressure to give a solid, which was recrystallized from C 4 lower fatty alcohol, and the solid was filtered off and the solid was washed with acetone or diethyl ether and dried.
  • the DL-ephedrine used in the present invention may be natural DL-ephedrine or artificially synthesized DL-ephedrine or a derivative thereof.
  • Another aspect of the invention also relates to a method for recovering a resolving agent D-(+)- or L-(-)-tartaric acid or a derivative thereof, which comprises subjecting an organic layer separated in an acidifying treatment step to distillation, recovering a solvent The residue obtained is the recovered resolving agent D-(+)- or L-(-) tartaric acid or a derivative thereof.
  • DL-ephedrine and D-(+) or L-(-)-dibenzoyltartaric acid are in a certain molar ratio (10.1 - 1:1.2, preferably in a ratio of 1:0.25 - 1:0.75, particularly preferred The ratio is 1:0.25), and then d-lower aliphatic alcohol is added thereto, such as methanol, ethanol or isopropanol, particularly preferably methanol, to completely dissolve it.
  • d-lower aliphatic alcohol such as methanol, ethanol or isopropanol, particularly preferably methanol, to completely dissolve it.
  • the volume is the same as that of the alcohol.
  • the temperature of the water was stirred for 20 to 60 minutes, left at room temperature (20 ° C) overnight, and the crystals were filtered out, and the mother liquor was recovered for the next experiment.
  • the filtered crystals are washed with acetone or diethyl ether and dried to give D-(-) ephedrine D-(+)-dibenzoyl tartrate or L-(+) ephedrine L-(-)-dibenzoyl. Tartrate.
  • a certain amount of D-(+) or L-(-)-dibenzoyltartaric acid is added to the mother liquor recovered in the above step, and the amount of the resolving agent added is determined by the yield of the previous step.
  • the mother liquid is reserved for the next experiment; the crystal is washed with acetone or ether, and the part is D+ after drying.
  • the mother liquid obtained above was evaporated under reduced pressure to remove water and alcohol, and toluene was added thereto, toluene was added thereto, and the mixture was heated under reflux for 4 hours. After cooling, the solid was filtered, and the mother liquid was recovered for the next step; the solid was washed with acetone or diethyl ether and dried. L-(+) ephedrine D-(+)-dibenzoyl tartrate or D-(-) ephedrine L-(-)-dibenzoyl tartrate.
  • the obtained D-(-) ephedrine D-(+)-dibenzoyl tartrate or L-(+) ephedrine L+)-dibenzoyl tartrate is added at a concentration of 0.5N to 2.5N, preferably 1N.
  • the organic layer separated in the above step is evaporated to recover a solvent, and the obtained residue is a recovered resolving agent D-(+)- or L+)-dibenzoyltartaric acid.
  • D-(+)-dibenzoyltartaric acid can be used as a resolving agent; likewise, D-(+) and L-(-) as shown in formula (I) are applied.
  • Derivatives of tartaric acid can be used to resolve DL-ephedrine or a derivative thereof, and DL as shown in formula (II) can be resolved by using D-(+) or L-(-)-dibenzoyltartaric acid.
  • the outstanding feature of the method of the invention is that L-(+)-ephedrine or its derivative and D-(-)-ephedrine or both are obtained simultaneously in a good yield in one resolution. Its derivative, and the resolving agent D-(+) or L-(-)-dibenzoyltartaric acid derivative can be recovered. detailed description The following examples will further illustrate the invention but are not intended to limit the invention.
  • step 5 The solid D-(-) ephedrine L-(+ dibenzoyl tartrate salt 15.0g obtained in step 4 was added to 50 ml of IN hydrochloric acid, stirred at room temperature to completely dissolve, and divided into 100.0 ml of diethyl ether. After the second extraction, the ether layer is separated to recover the resolving agent; the aqueous layer is evaporated under reduced pressure to obtain a solid, which is recrystallized from anhydrous ethanol, and crystals are filtered out, and the mother liquid is retained for recovery of DL-ephedrine. Wash and dry to obtain 7.57g D-(-) ephedrine hydrochloride, mp: 219-221 °C

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to the process for resolving DL-ephedrine, DL-pseudoephedrine or the derivatives thereof and to the corresponding resolving agents. The D-(+)- or L-(-)-tartaric acid derivatives of formula (I) are the resolving agents for DL-ephedrine of formula (II), DL-pseudoephedrine of formula (III), in which the groups in formulas (I) to (III) are defined as claims.

Description

DL-麻黄碱、 DL-伪麻黄碱或其衍生物的拆分方法以及相应的拆分剂  Resolution method of DL-ephedrine, DL-pseudoephedrine or its derivative and corresponding resolving agent
技术领域 Technical field
本发明涉及 D-(+)-或 L- (-) -酒石酸或其衍生物作为 DL-麻黄 碱或其衍生物的拆分剂及其拆分方法。 本发明还涉及拆分剂的回 收方法。 背景技术  The present invention relates to a D-(+)- or L-(-)-tartaric acid or a derivative thereof as a resolving agent for DL-ephedrine or a derivative thereof and a method for its resolution. The invention also relates to a recovery method for a resolving agent. Background technique
麻黄碱化学名为 1-苯基 -2-甲氨基 -1-丙醇, 由于其 1 位和 2 位为手性碳原子, 故此类化合物共有四种异构体, 即 D- ( - ) -麻 黄碱 (天然) 和 L- ( + ) -麻黄碱(非天然) 以及 L- ( + ) -伪麻 黄碱 (天然) 和 D- ( - ) -伪麻黄碱(非天然) , 其结构如下:  The chemical name of ephedrine is 1-phenyl-2-methylamino-1-propanol. Since the 1- and 2-positions are chiral carbon atoms, there are four isomers of this kind of compound, namely D-(-)- Ephedrine (natural) and L- ( + ) - ephedrine (non-natural) and L- ( + ) - pseudoephedrine (natural) and D- ( - ) - pseudoephedrine (non-natural), the structure is as follows:
Figure imgf000003_0001
Figure imgf000003_0001
1R, 2R-D- (-) -伪麻黄碱 lS, 2S-L<+)>伪麻黄碱 li^S- D ) -麻黄碱 1 S, 2R-L>(+)-庥黄碱 中国是世界上唯一的天然麻黄减生产国, 所生产的麻黄素全 部采用天然植物麻黄的全草。 麻黄草的产地主要集中在中国西部 地区的新疆、 内蒙、 甘肃、 宁夏等地, 每年仅新疆地区, 消耗麻 黄草的量在 8 ~ 10万吨左右。 由于生长麻黄草的主产区是中国沙 漠化最为严重的地方, 而麻黄草又是这些地区的主要固沙植物; 所以, 近年来麻黄草的过度采挖, 已经对这些地区的生态环境造 成了严重影响。 因此, 以化学合成手段生产符合市场要求的麻黄 素将是减少麻黄草的采挖、 保护生态环境、 满足市场需求的有效 的途径。 目前, 化学合成手段生产麻黄素面临的主要问题是如何低成 本地得到光学纯产物; 虽然不对称合成的方法已得到很大的发 展, 但有工业价值的方法并不多。 文献报道且有实用价值的都是 结晶法: 向 DL-麻黄碱的水、 有机溶剂、 或水和有机溶剂形成的 混合溶剂的溶液中加入一种手性酸(拆分剂) , 形成非对映异构 体, 利用非对映异构体在溶剂中的溶解度不同而使其中之一优先 析出。 目前文献披露的 DL-麻黄碱或其衍生物的拆分方法主要有 以下几种: 1R, 2R-D- (-) - pseudoephedrine lS, 2S-L<+)> pseudoephedrine li^S- D ) - ephedrine 1 S, 2R-L>(+)- strontium China is the only one in the world Natural ephedra is reduced in the producing country, and the ephedrine produced is all whole grass of natural plant ephedra. The origin of ephedra is mainly concentrated in Xinjiang, Inner Mongolia, Gansu, Ningxia and other places in western China. The annual consumption of ephedra is only about 80,000 to 100,000 tons in Xinjiang alone. Because the main producing area of growing ephedra is the most serious desertification in China, and ephedra is the main sand fixing plant in these areas; therefore, the excessive excavation of ephedra has caused serious impact on the ecological environment of these areas in recent years. . Therefore, the production of ephedrine that meets market requirements by chemical synthesis will be an effective way to reduce the extraction of ephedra, protect the ecological environment, and meet market demand. At present, the main problem faced by chemical synthesis in the production of ephedrine is how to obtain optically pure products at low cost; although the method of asymmetric synthesis has been greatly developed, there are not many methods of industrial value. It is reported in the literature that there is practical value in the crystallization method: adding a chiral acid (resolving agent) to a solution of DL-ephedrine in water, an organic solvent, or a mixed solvent of water and an organic solvent to form a non-pair The isomers are preferentially precipitated by utilizing the solubility of the diastereomers in a solvent. At present, there are mainly the following methods for the resolution of DL-ephedrine or its derivatives disclosed in the literature:
1 ) L-(+)-苦杏仁酸和 D-(-)-苦杏仁酸为拆分剂 ( a), U.S. Patent: 1867274; b), J, Am. Chem. Soc., 1929, 51: 1906. ): 此方 法的优点是拆分效率高 (75%以上) ; 产品光学纯度高 (99%以 上) 。 缺点是: L-(+)-苦杏仁酸和 D-(-)-苦杏仁酸不易得到, 价 格高, 不能适应大工业化生产的要求。  1) L-(+)-mandelic acid and D-(-)-mandelic acid are resolving agents (a), US Patent: 1867274; b), J, Am. Chem. Soc., 1929, 51: 1906. ): The advantage of this method is that the resolution is high (more than 75%); the optical purity of the product is high (more than 99%). Disadvantages are: L-(+)-mandelic acid and D-(-)-mandelic acid are not easily available, and the price is high, which cannot meet the requirements of large industrial production.
2 ) L-(+)-酒石酸为拆分剂: 天然的 L-(+)-酒石酸作为拆分剂 具有极大的吸引力, 因为其价格之便宜使得人们可以不考虑其回 收。 如能利用 L-(+)-酒石酸将 DL-麻黄碱拆分, 将会是一种具有 工业价值的方法。 有多篇文献 ( a), U.K. Patent: 354975, 356931; b), Ger. Patent: DE549970; c), J. Pharm. Soc. Japan, 1927, 47: 109. ) 尝试过使用 L-(+)-酒石酸拆分 DL-麻黄碱或其衍 生物的方法, 但也有文献 ( J, Am, Chem. Soc, 1929, 51: 1906. ) 证明此方法不可能成功拆分 DL-麻黄碱或其衍生物。  2) L-(+)-tartaric acid is a resolving agent: Natural L-(+)-tartaric acid is a great repellent because its price is cheap so that people can ignore it. If L-(+)-tartaric acid can be used to separate DL-ephedrine, it will be an industrially valuable method. There are many articles (a), UK Patent: 354975, 356931; b), Ger. Patent: DE549970; c), J. Pharm. Soc. Japan, 1927, 47: 109. ) Trying to use L-(+) - a method for the resolution of DL-ephedrine or a derivative thereof by tartaric acid, but there is also literature (J, Am, Chem. Soc, 1929, 51: 1906.) which proves that this method cannot successfully resolve DL-ephedrine or its derivative .
3 ) 利用 D-arabonic acid为拆分剂 ( US Patent 3478101 ) : 此方法的优点是: 产物的拆分率 (80%以上) 和光学纯度都较 高, 且拆分剂可以回收利用。 但 D-arabonic acid价格昂贵, 不 易得到。  3) Using D-arabonic acid as a resolving agent (US Patent 3478101): The advantages of this method are: the product resolution (80% or more) and optical purity are high, and the resolving agent can be recycled. However, D-arabonic acid is expensive and not readily available.
此外, 还有文献报道利用 N-苄氧羰基 -DL-氨基酸交换拆分 DL-麻黄碱或其衍生物 (/· Chin. Chem. Soc. (Taipei), 1978, 25(4): 209-14. ) 以及利用 D-2,4-二氯苯氧基丙酸拆分 DL-麻黄碱或其衍 生物 U. S. Patent: 6015903、 的方法, 但这两种拆分剂的价格也 都较昂贵。 In addition, it has been reported in the literature to resolve DL-ephedrine or its derivatives by N-benzyloxycarbonyl-DL-amino acid exchange (/· Chin. Chem. Soc. (Taipei), 1978, 25(4): 209-14.) and the method of dissolving DL-ephedrine or a derivative thereof by using D-2,4-dichlorophenoxypropionic acid, US Patent: 6015903, but the prices of the two resolving agents are also relatively high. expensive.
另有文献显示, 二苯甲酰基酒石酸衍生物可作为制备光学活 性的 N-苄基 -3-氨基吡咯烷( JP 09176115 A2 ) 的拆分剂。  Further literature has shown that dibenzoyltartaric acid derivatives can be used as resolving agents for the preparation of optically active N-benzyl-3-aminopyrrolidines ( JP 09176115 A2 ).
发明内容 生物的方法。 SUMMARY OF THE INVENTION Biological methods.
本发明者经过研究发现, 下述式 (I ) D-(+)-或 L- (-) -酒石酸 或其衍生物在麻黄碱或其衍生物的拆分中显示出优良的效果, 从而为工业化生产光学活性的麻黄碱或其衍生物及环境保护提 供了有力的保证。  The present inventors have found through research that the following formula (I) D-(+)- or L-(-)-tartaric acid or a derivative thereof exhibits an excellent effect in the resolution of ephedrine or a derivative thereof, thereby The industrial production of optically active ephedrine or its derivatives and environmental protection provides a strong guarantee.
因此, 本发明的一个方面涉及式 (I ) 所示的 D-(+)-或 L-(-)- 酒石酸或其衍生物作为拆分 DL-麻黄碱或其衍生物的拆分剂:  Accordingly, one aspect of the present invention relates to D-(+)- or L-(-)-tartaric acid or a derivative thereof represented by the formula (I) as a resolving agent for the resolution of DL-ephedrine or a derivative thereof:
Figure imgf000005_0001
Figure imgf000005_0001
( I ) 其中, 取代基 R各自独立为 H、 CH3、 Cl、 F和 N02(I) wherein the substituents R are each independently H, CH 3 , Cl, F and N0 2 .
本发明中所用的术语" DL-麻黄碱或其衍生物"是指式 (II ) DL-麻黄碱或其衍生物, 或式(III ) DL-伪麻黄碱或其衍生物:  The term "DL-ephedrine or a derivative thereof" as used in the present invention means DL-ephedrine or a derivative thereof of the formula (II), or DL-pseudoephedrine or a derivative thereof of the formula (III):
Figure imgf000005_0002
其中,
Figure imgf000005_0002
among them,
式 (II) 中, R2各自独立为 H、 Ci Cs直链或支链烷 基, R3、 R4各自独立为 Η、 ΟΗ、 ι¾素、 N02或 直链或 支链烷基、 <^~<3直链或支链烷氧基, In the formula (II), R 2 is each independently H, Ci Cs linear or branched alkyl, and R 3 and R 4 are each independently Η, ΟΗ, ι3⁄4, N0 2 or a linear or branched alkyl group, <^~< 3 linear or branched alkoxy groups,
式 (III) 中, R 、 R2, 各自独立为 H、 d~C5直链或支链 烷基, R3,、 R4,各自独立为 H、 OH、 卤素、 N02或 d~C3直链 或支链烷基、 直链或支链烷氧基。 In the formula (III), R and R 2 are each independently H, d to C 5 linear or branched alkyl, R 3 , and R 4 are each independently H, OH, halogen, N0 2 or d~C. 3 straight or branched alkyl, straight or branched alkoxy.
根据本发明的一个实施方案, 用上述式 (I) D-或 L-构型酒 石酸衍生物作为 DL-麻黄碱或其衍生物的拆分剂。  According to one embodiment of the present invention, the D- or L-configuration tartaric acid derivative of the above formula (I) is used as a resolving agent for DL-ephedrine or a derivative thereof.
才艮据本发明的一个优选实施方案, 用上述式 (I) D-或 L-构 型酒石酸衍生物作为式 (II) DL-麻黄碱或其衍生物或式 (III) DL-伪麻黄碱或其衍生物的拆分剂。  According to a preferred embodiment of the present invention, the D- or L-configuration tartaric acid derivative of the above formula (I) is used as the DL-ephedrine of the formula (II) or a derivative thereof or the DL-pseudoephedrine of the formula (III) or Resolving agent for derivatives.
才艮据本发明的另一个优选实施方案, 用如式(IV) 所示的 D -或 L-构型的酒石酸作为 DL-麻黄碱或其衍生物的拆分剂:  According to another preferred embodiment of the present invention, tartaric acid of the D- or L-configuration as shown in formula (IV) is used as a resolving agent for DL-ephedrine or a derivative thereof:
Figure imgf000006_0001
Figure imgf000006_0001
根据本发明的另一个优选实施方案, 用如上述式 (IV) 所示 的 D-或 L-构型的酒石酸作为式(II) DL-麻黄碱或其衍生物 或式 (III) DL-伪麻黄碱或其衍生物的拆分剂: According to another preferred embodiment of the present invention, tartaric acid of the D- or L-configuration as shown in the above formula (IV) is used as the DL-ephedrine of the formula (II) or a derivative thereof or the DL-pseudoephedrine of the formula (III) Resolving agent for its or its derivatives:
根据本发明特别优选的实施方案, 用如上述的式 (IV) 所示 的酒石酸作为式 (V) DL-麻黄碱的拆分剂:
Figure imgf000007_0001
本发明的另一个方面涉及拆分 DL-麻黄碱或其衍生物的方 法, 其包括使式(I ) 所示的 D-(+)-或 L- (-) -酒石酸衍生物与 DL- 麻黄碱或其衍生物以一定的摩尔比接触, 经常规处理, 得到 DL- 麻黄碱或其衍生物与拆分剂结合的晶体, 所得晶体经过酸化处 理, 即得到光学活性麻黄碱或其衍生物异构体。
According to a particularly preferred embodiment of the present invention, tartaric acid represented by the above formula (IV) is used as a resolving agent for the formula (V) DL-ephedrine:
Figure imgf000007_0001
Another aspect of the invention relates to a method for the resolution of DL-ephedrine or a derivative thereof, which comprises the D-(+)- or L-(-)-tartaric acid derivative represented by formula (I) and DL-ephedra The alkali or a derivative thereof is contacted at a certain molar ratio, and is subjected to a conventional treatment to obtain a crystal in which DL-ephedrine or a derivative thereof is combined with a resolving agent, and the obtained crystal is acidified to obtain an optically active ephedrine or a derivative thereof. Structure.
本发明所使用的术语 "常规处理"是指向 DL -麻黄碱或其衍 生物与拆分剂組成的混合物中加入 QrC4低级脂肪醇,使之完全 溶解, 在 50 ~ 70°C下, 加入与醇等体积、 同温度的水, 搅拌 20 - 60 分钟, 室温放置过夜, 滤出固体并回收母液, 固体以丙 酮或乙醚洗涤并干燥。 The term "conventional treatment" as used in the present invention refers to the addition of QrC 4 lower aliphatic alcohol to a mixture of DL-ephedrine or a derivative thereof and a resolving agent, to completely dissolve it, at 50 to 70 ° C, and An equal volume of alcohol, water of the same temperature, stirred for 20-60 minutes, allowed to stand at room temperature overnight, the solid was filtered off and the mother liquid was recovered, and the solid was washed with acetone or diethyl ether and dried.
本发明所使用的术语" 酸化处理"是指向所得的 DL -麻黄碱 或其衍生物与拆分剂形成的结合物的晶体中加入 0.5N-2.5N适量 的无机酸如稀盐酸, 在 20 - 40°C下搅拌使之完全溶解, 用有机 溶剂提取两次, 水层减压蒸发得固体, 用 C4低级脂肪醇重 结晶, 滤出固体并回收母液, 固体以丙酮或乙醚洗涤并干燥。 The term "acidification treatment" as used in the present invention refers to the addition of 0.5 N to 2.5 N of an appropriate amount of a mineral acid such as dilute hydrochloric acid to the crystal of the conjugate of the obtained DL-ephedrine or a derivative thereof and the resolving agent, at 20 - The mixture was completely dissolved by stirring at 40 ° C, extracted twice with an organic solvent, and the aqueous layer was evaporated under reduced pressure to give a solid, which was recrystallized from C 4 lower fatty alcohol, and the solid was filtered off and the solid was washed with acetone or diethyl ether and dried.
根据本发明, 本发明中所用 DL-麻黄碱可以是天然的 DL - 麻黄碱或人工化学合成的 DL -麻黄碱或其衍生物。  According to the present invention, the DL-ephedrine used in the present invention may be natural DL-ephedrine or artificially synthesized DL-ephedrine or a derivative thereof.
本发明的另一个方面还涉及拆分剂 D-(+)-或 L- (-) -酒石酸或 其衍生物的回收方法, 其包括对酸化处理步骤中分出的有机层进 行蒸馏, 回收溶剂, 得到的残留物即为回收的拆分剂 D-(+)-或 L- (-)酒石酸或其衍生物。  Another aspect of the invention also relates to a method for recovering a resolving agent D-(+)- or L-(-)-tartaric acid or a derivative thereof, which comprises subjecting an organic layer separated in an acidifying treatment step to distillation, recovering a solvent The residue obtained is the recovered resolving agent D-(+)- or L-(-) tartaric acid or a derivative thereof.
根据本发明, 以采用式 (IV) L- (-) -二苯甲酰基酒石酸作为拆 分剂为例, 式 (V) DL-麻黄碱可按以下路线进行拆分: DL-麻昔减 二苯甲 fe^酒石酸(mol比 =1:0.25 ) According to the present invention, by using L-(-)-dibenzoyltartaric acid of the formula (IV) as a resolving agent, the DL-ephedrine of the formula (V) can be resolved by the following route: DL-Mahoximin benzophenone fe^ tartaric acid (mol ratio = 1:0.25)
甲醇: 1: 1 加热溶解, ^Hp  Methanol: 1: 1 heated to dissolve, ^Hp
L-(+)-麻昔碱 L-i-)-二苯甲 酒石 母液 L-(+)-methicin L-i-)-diphenyl tartar mother liquor
(晶体、 滤出) L- (-) -二苯甲 酒石酸  (crystal, filtered out) L- (-) -benzil tartaric acid
晶体、 滤出  Crystal, filtered out
酸化 ( 1N HCI),' f 1  Acidification ( 1N HCI), ' f 1
L-W-麻昔减 L-A-二笨甲 酒石 母液  L-W-Mahoximin L-A-Two stupid tartar mother liquor
L +)-麻昔滅 酸化(1NHC1) ^ , 甲苯回流 麻黃戯 D-f-)-麻昔緘 L-i-)-二苯甲 酒石  L +)-Mexoxime Acidification (1NHC1) ^ , Toluene reflux Ephedra play D-f-)-Maspoxib L-i-)-Diphenyl tartar
酸化 ( 1NHC1) 麻黃  Acidification ( 1NHC1) ephedra
具体来讲, 在上面的拆分路线中:  Specifically, in the split route above:
将 DL-麻黄碱和 D-(+)或 L-(-)-二苯甲酰基酒石酸以一定摩 尔比 ( 1:0.1 - 1:1.2, 优选比例为 1:0.25 - 1:0.75, 特别优选的比 例是 1:0.25 ) 混合, 然后向其中加入 d - 低级脂肪醇, 如甲 醇、 乙醇或异丙醇、 特别优选甲醇使之完全溶解, 在 50 ~ 70°C 下, 加入与醇等体积、 同温度的水, 搅拌 20 ~ 60 分钟, 室温 (20°C)放置过夜, 过滤出晶体, 母液回收用于下一步实验。 过滤 出的晶体以丙酮或乙醚洗涤, 干燥即得 D- (-)麻黄碱 D-(+)-二苯 甲酰基酒石酸盐或 L-(+)麻黄碱 L- (-) -二苯甲酰基酒石酸盐。  DL-ephedrine and D-(+) or L-(-)-dibenzoyltartaric acid are in a certain molar ratio (10.1 - 1:1.2, preferably in a ratio of 1:0.25 - 1:0.75, particularly preferred The ratio is 1:0.25), and then d-lower aliphatic alcohol is added thereto, such as methanol, ethanol or isopropanol, particularly preferably methanol, to completely dissolve it. At 50 to 70 ° C, the volume is the same as that of the alcohol. The temperature of the water was stirred for 20 to 60 minutes, left at room temperature (20 ° C) overnight, and the crystals were filtered out, and the mother liquor was recovered for the next experiment. The filtered crystals are washed with acetone or diethyl ether and dried to give D-(-) ephedrine D-(+)-dibenzoyl tartrate or L-(+) ephedrine L-(-)-dibenzoyl. Tartrate.
向以上步骤回收的母液中再次加入一定量的 D-(+)或 L- (-) - 二苯甲酰基酒石酸, 所加入的拆分剂的量由前一步骤的收率决 定。 在 60 ~ 70°C下, 加热搅拌使之完全溶解, 室温 (20°C)放置过 夜, 过滤出晶体, 母液保留用于下一步实验; 晶体以丙酮或乙 醚洗涤, 干燥又可得部分 D+)麻黄碱 D-(+)-二苯甲酰基酒石酸 盐或 L-(+)麻黄碱 L- (-) -二苯甲酰基酒石酸盐。 将以上所得的母液減压蒸去水和醇得稠状物, 向其中加入甲 苯, 加热回流 4小时, 冷却后过滤出固体, 母液回收用于下一步 实验; 固体以丙酮或乙醚洗涤, 干燥得 L- (+)麻黄碱 D-(+)-二苯 甲酰基酒石酸盐或 D- (-)麻黄碱 L- (-) -二苯甲酰基酒石酸盐。 A certain amount of D-(+) or L-(-)-dibenzoyltartaric acid is added to the mother liquor recovered in the above step, and the amount of the resolving agent added is determined by the yield of the previous step. At 60 ~ 70 ° C, stir it to dissolve completely, place it at room temperature (20 ° C) overnight, filter out the crystal, the mother liquid is reserved for the next experiment; the crystal is washed with acetone or ether, and the part is D+ after drying. Ephedrine D-(+)-dibenzoyl tartrate or L-(+) ephedrine L-(-)-dibenzoyl tartrate. The mother liquid obtained above was evaporated under reduced pressure to remove water and alcohol, and toluene was added thereto, toluene was added thereto, and the mixture was heated under reflux for 4 hours. After cooling, the solid was filtered, and the mother liquid was recovered for the next step; the solid was washed with acetone or diethyl ether and dried. L-(+) ephedrine D-(+)-dibenzoyl tartrate or D-(-) ephedrine L-(-)-dibenzoyl tartrate.
将所得的 D- (-)麻黄碱 D-(+)-二苯甲酰基酒石酸盐或 L-(+)麻 黄碱 L+)-二苯甲酰基酒石酸盐加入浓度为 0.5N ~ 2.5N、 优选 1N 的适量稀盐酸, 在 20 ~ 40。C下搅拌使之完全溶解, 以一种有 机溶剂, 例如乙醚、 乙酸乙酯或甲苯、 特别优选乙醚, 分两次提 取, 分出有机层以回收拆分剂; 水层减压蒸去水得固体, 以 d - C4低级脂肪醇如甲醇、 乙醇或异丙醇、 特别优选无水乙醇或 95%乙醇重结晶, 过滤出晶体, 母液保留用于回收 DL-麻黄碱。 过滤出的晶体以丙酮或乙醚洗涤, 干燥即得 D- (-)麻黄碱或 L-(+) 麻黄碱盐酸盐。 采用本方法获得的拆分收率在 75 %以上。 The obtained D-(-) ephedrine D-(+)-dibenzoyl tartrate or L-(+) ephedrine L+)-dibenzoyl tartrate is added at a concentration of 0.5N to 2.5N, preferably 1N. The right amount of dilute hydrochloric acid, in the 20 ~ 40. C is stirred to completely dissolve, and extracted in two organic solvents, such as diethyl ether, ethyl acetate or toluene, particularly preferably diethyl ether, and the organic layer is separated to recover the resolving agent; the solid to d - C 4 lower aliphatic alcohols such as methanol, ethanol or isopropanol, particularly preferably ethanol or 95% ethanol and recrystallized, crystals were filtered off, mother liquor was retained for recovery of DL- ephedrine. The filtered crystals are washed with acetone or diethyl ether and dried to give D-(-) ephedrine or L-(+) ephedrine hydrochloride. The resolution obtained by this method is above 75%.
将上述步骤分出的有机层蒸镏回收溶剂, 所得残留物即为回 收的拆分剂 D-(+)-或 L+)-二苯甲酰基酒石酸。  The organic layer separated in the above step is evaporated to recover a solvent, and the obtained residue is a recovered resolving agent D-(+)- or L+)-dibenzoyltartaric acid.
采用与上述相同的方法, 可以以 D-(+)-二苯甲酰基酒石酸作 为拆分剂进行拆分; 同样, 应用如式 ( I ) 所示的 D-(+)和 L- (-) 构型酒石酸的衍生物可以拆分 DL-麻黄碱或其衍生物, 并且, 应 用 D-(+)或 L- (-) -二苯甲酰基酒石酸可以拆分如式 (II ) 所示的 DL-麻黄碱或其衍生物或如式 (III)所示的 DL-伪麻黄碱或其衍生 物。  In the same manner as above, D-(+)-dibenzoyltartaric acid can be used as a resolving agent; likewise, D-(+) and L-(-) as shown in formula (I) are applied. Derivatives of tartaric acid can be used to resolve DL-ephedrine or a derivative thereof, and DL as shown in formula (II) can be resolved by using D-(+) or L-(-)-dibenzoyltartaric acid. - ephedrine or a derivative thereof or DL-pseudoephedrine or a derivative thereof as shown in formula (III).
相对于现有技术, 本发明方法的突出特点是在一次拆分过程 中以较好的收率同时得到了 L-(+)-麻黄碱或其衍生物和 D- (-) -麻 黄碱或其衍生物, 并且可以回收拆分剂 D-(+)或 L- (-) -二苯甲酰基 酒石酸衍生物。 具体实施方式 下列实施例将进一步描述本发明, 但并不限制本发明。 Compared with the prior art, the outstanding feature of the method of the invention is that L-(+)-ephedrine or its derivative and D-(-)-ephedrine or both are obtained simultaneously in a good yield in one resolution. Its derivative, and the resolving agent D-(+) or L-(-)-dibenzoyltartaric acid derivative can be recovered. detailed description The following examples will further illustrate the invention but are not intended to limit the invention.
实施例 1: DL-麻黄碱的制备  Example 1: Preparation of DL-ephedrine
将 201.5g DL-麻黄碱益酸盐溶解于 1500ml IN NaOH中, 同 时加热使之完全溶解, 室温放置后有大量固体析出, 过滤出固 体, 母液以乙醚提取, 无水 Na2S04干燥, 过滤除去干燥剂, 蒸 去乙醚得固体, 两次得到的固体合并, 干燥, 得到 156.0g DL-麻 黄碱, mp: 76-78 °C o 实施例 2: 应用 L- (-) -二苯甲酰基酒石酸拆分 DL-麻黄碱 201.5 g of DL-ephedrine beneficial acid salt was dissolved in 1500 ml of IN NaOH, and heated to dissolve completely. After standing at room temperature, a large amount of solid precipitated, and the solid was filtered out. The mother liquid was extracted with diethyl ether, dried over anhydrous Na 2 SO 4 , filtered. The desiccant was removed, and diethyl ether was evaporated to give a solid. The solid obtained twice was combined and dried to give 156.0 g of DL- ephedrine, mp: 76-78 ° C. Example 2: Application of L-(-)-dibenzoyl Tartaric acid split DL-ephedrine
1 ) 将 16.5g (O.lmol)的 DL-麻黄碱和 9.4g (0.025mol)的 L- (- )-二苯甲酰基酒石酸一水合物溶解于 30.0ml 的无水甲醇中, 在 60-70Ό下, 加入 30ml 同温度的水, 搅拌使之完全溶解, 室温 (20°C)放置过夜, 过滤出晶体, 母液回收用于下步实验。 过滤出 的晶体以丙酮洗涤, 干燥即得 14.2gL-(+)麻黄碱 L- (-) -二苯甲酰 基酒石酸盐, mp: 178-179。C。  1) 16.5 g (0.1 mol) of DL-ephedrine and 9.4 g (0.025 mol) of L-(-)-dibenzoyltartaric acid monohydrate were dissolved in 30.0 ml of anhydrous methanol at 60- Under 70 Torr, add 30 ml of water of the same temperature, stir to dissolve completely, place at room temperature (20 ° C) overnight, filter out the crystals, and recover the mother liquor for the next step. The filtered crystals were washed with acetone and dried to give 14.2 g of L-(+) ephedrine L-(-)-dibenzoyl tartrate, mp: 178-179. C.
2 ) 向步骤 1 回收的母液中加入 7.7g (0.02mol) L- (-) -二苯 甲酰基酒石酸, 在 60-70°C下, 加热搅拌使之完全溶解, 室温 (20°C)放置过夜, 过滤出晶体, 母液回收用于下一步实验。 过滤 出的晶体以丙酮洗涤, 干燥即得 2.6g L-(+)麻黄碱 L-(-)-二苯甲 酰基酒石酸盐, mp: 173-175°C。  2) Add 7.7g (0.02mol) of L-(-)-dibenzoyltartaric acid to the mother liquor recovered in step 1, and dissolve it at 60-70 ° C with heating and stirring. Place at room temperature (20 ° C). Over the night, the crystals were filtered off and the mother liquor was recovered for the next experiment. The filtered crystals were washed with acetone and dried to give 2.6 g of L-(+) ephedrine L-(-)-dibenzoyl tartrate, mp: 173-175 °C.
3 ) 将 1和 2所得的 L-(+)麻黄碱 L- (-) -二苯甲酰基酒石酸 盐合并共计 16.8g, 加入 60.0ml IN 的盐酸, 室温搅拌使之完全 溶解, 以 100.0ml 乙醚分两次提取, 分出乙醚层以回收拆分剂; 水层减压蒸去水得固体, 以无水乙醇重结晶, 过滤出晶体, 母液 保留用于回收 DL-麻黄碱。 过滤出的晶体以丙酮洗涤, 干燥即得 8.84g L-(+)麻黄碱盐酸盐, 收率: 88.4%, mp: 218-220°C , [a]D 20= +33.4。(5·1%,水); 1H-NMR(400MHz, CDC13): 59.00910 (brs, 2H), 7.41133-7.35411 (m, 4H), 7.30091-7.25811 (m, 1H), 6.13991 (d, 1H, /=4.416Hz), 5.18129 (dd, 1H, !=4.196Hz, 2=2.672Hz), 3.33266 (q, 1H, /=4.808Hz), 2.61408 (s, 3H), 0.92060 (d, 3H,/=6.736Hz)。 3) Combine L-(+) ephedrine L-(-)-dibenzoyl tartrate obtained in 1 and 2 to a total of 16.8 g, add 60.0 ml of IN hydrochloric acid, stir at room temperature to completely dissolve, to 100.0 ml of ether. The extract was extracted twice, and the ether layer was separated to recover the resolving agent; the aqueous layer was evaporated under reduced pressure to give a solid, which was recrystallized from anhydrous ethanol, and crystals were filtered, and the mother liquid was retained for recovery of DL-ephedrine. The crystals which were filtered were washed with acetone and dried to give 8.84 g of L-(+) ephedrine hydrochloride, yield: 88.4%, mp: 218-220 ° C, [a] D 20 = +33.4. (5·1%, water); 1 H-NMR (400MHz, CDC1 3 ): 59.00910 (brs, 2H), 7.41133-7.35411 (m, 4H), 7.30091-7.25811 (m, 1H), 6.13991 (d, 1H, /=4.416Hz), 5.18129 (dd, 1H, !=4.196Hz, 2=2.672 Hz), 3.33266 (q, 1H, /=4.808Hz), 2.61408 (s, 3H), 0.92060 (d, 3H, /=6.736Hz).
4 ) 将步骤 2的母液减压蒸去水和甲醇得稠状物, 向其中加 入 100.0ml甲苯, 加热回流 4小时, 冷却后过滤出固体, 母液回 收用于下一步实验; 固体以丙酮洗涤, 干燥得 15.0g D-(-)麻黄碱 L-(+二苯甲酰基酒石酸盐, mp: 170-172°C。  4) The mother liquid of the step 2 was evaporated under reduced pressure to remove water and methanol to obtain a thick material. 100.0 ml of toluene was added thereto, and the mixture was heated under reflux for 4 hours. After cooling, the solid was filtered, and the mother liquid was recovered for the next experiment; the solid was washed with acetone. Drying gave 15.0 g of D-(-) ephedrine L-(+ dibenzoyl tartrate, mp: 170-172 °C.
5 ) 将步骤 4中所得到的固体 D- (-)麻黄碱 L-(+二苯甲酰基 酒石酸盐 15.0g 加入到 50ml IN 的盐酸中, 室温搅拌使之完全 溶解, 以 100.0ml 乙醚分两次提取, 分出乙醚层以回收拆分剂; 水层减压蒸去水得固体, 以无水乙醇重结晶, 过滤出晶体, 母液 保留用于回收 DL-麻黄碱。 过滤出的晶体以丙酮洗涤, 干燥即得 7.57g D- (-)麻黄碱盐酸盐, mp: 219-221 °C„  5) The solid D-(-) ephedrine L-(+ dibenzoyl tartrate salt 15.0g obtained in step 4 was added to 50 ml of IN hydrochloric acid, stirred at room temperature to completely dissolve, and divided into 100.0 ml of diethyl ether. After the second extraction, the ether layer is separated to recover the resolving agent; the aqueous layer is evaporated under reduced pressure to obtain a solid, which is recrystallized from anhydrous ethanol, and crystals are filtered out, and the mother liquid is retained for recovery of DL-ephedrine. Wash and dry to obtain 7.57g D-(-) ephedrine hydrochloride, mp: 219-221 °C
6 ) 向步骤 4 回收的母液 (甲苯层) 加入 30ml I 的盐 酸, 充分搅拌后分出水层, 甲苯层保留以回收拆分剂; 水层減压 蒸去水得固体, 以无水乙醇重结晶, 过滤出晶体, 母液保留用于 回收 DL-麻黄碱。 过滤出的晶体以丙酮洗涤, 干燥即得 D- (-)麻 黄碱盐酸盐 0.68g, mp: 219-221。C。 将步骤 5)和步骤 6)所得的 D - (-)麻黄碱盐酸盐合并得 8.25g 产品, 收率: 82·5%, [a]D 20= - 34.0。(5.2%,水); 1H-NMR(400MHz, CDC13): 58.99578 (brs, 2H), 7.40512-7.35511 (m, 4H), 7.30183-7.26520 (m, 1H), 6.14056 (d, 1H
Figure imgf000011_0001
3.33387 (q, 1H, /=4.480Hz), 2.61443 (s, 3H), 0.92002 (d, 3H, /=6.708Hz)。
6) Add 30 ml of I hydrochloric acid to the mother liquor (toluene layer) recovered in step 4. After thoroughly stirring, the aqueous layer is separated, and the toluene layer is retained to recover the resolving agent; the aqueous layer is evaporated under reduced pressure to obtain a solid, which is recrystallized from absolute ethanol. The crystals are filtered out and the mother liquor is retained for recovery of DL-ephedrine. The filtered crystals were washed with acetone and dried to give D-(-) ephedrine hydrochloride 0.68 g, mp: 219-221. C. The D-(-) ephedrine hydrochloride salt obtained in the step 5) and the step 6) was combined to give 8.25 g of product, yield: 82.5%, [a] D 20 = - 34.0. (5.2%, water); 1 H-NMR (400MHz, CDC1 3 ): 58.99578 (brs, 2H), 7.40512-7.35511 (m, 4H), 7.30183-7.26520 (m, 1H), 6.14056 (d, 1H
Figure imgf000011_0001
3.33387 (q, 1H, /=4.480Hz), 2.61443 (s, 3H), 0.92002 (d, 3H, /=6.708Hz).
7 ) 将步骤 3和步骤 5所得的乙醚层合并, 蒸馏回收乙醚, 然后向残留物中加入步骤 6)所得的甲苯层, 蒸馏回收大部分甲 苯, 得 15.7g 固体, 此即为回收的拆分剂 L- (-) -二苯甲酰基酒石 酸, 回收率: 96.3%, mp: 148-150 °C, [a】D 2。= -118.8°(5.1%,甲 醇)。 7) The diethyl ether layers obtained in the steps 3 and 5 are combined, and the diethyl ether is distilled, and then the toluene layer obtained in the step 6) is added to the residue, and most of the toluene is distilled off to obtain 15.7 g of a solid, which is a recovered split. L-(-)-dibenzoyl tartar Acid, recovery: 96.3%, mp: 148-150 °C, [a] D 2 . = -118.8° (5.1%, methanol).
8 ) 将步骤 3、 步骤 5和步骤 6以乙醇重结晶的母液合并, 蒸馏回收乙醇, 得到 1.72g 固体, 此为没有拆分开的 DL-麻黄碱 盐酸盐。 实施例 3: 应用 D-(+)-二苯甲酰基酒石酸拆分 DL-麻黄碱  8) The mother liquors recrystallized from ethanol in steps 3, 5 and 6 were combined and the ethanol was distilled to obtain 1.72 g of solid, which was DL-ephedrine hydrochloride which was not separated. Example 3: Application D-(+)-dibenzoyltartaric acid resolution DL-ephedrine
1) 将 8.25g (0.05mol)的 DL-麻黄碱和 4.7g (0.0125mol)的 D-(+)-二苯甲酰基酒石酸一水合物溶解于 15.0ml的无水甲醇中, 在 50-60°C下, 加入 15.0ml同温度的水, 搅拌使之完全溶解, 室 温 (20°C)放置过夜, 过滤出晶体, 母液回收用于下一步实验。 过 滤出的晶体以丙酮洗涤, 干燥即得 7.5g D-(+麻黄碱 D-(+)-二苯 甲酰基酒石酸盐, mp: 172-173 °C。  1) 8.25 g (0.05 mol) of DL-ephedrine and 4.7 g (0.0125 mol) of D-(+)-dibenzoyltartaric acid monohydrate were dissolved in 15.0 ml of anhydrous methanol at 50-60 At ° C, 15.0 ml of water of the same temperature was added, stirred to completely dissolve, and left at room temperature (20 ° C) overnight, and the crystals were filtered off, and the mother liquor was recovered for the next experiment. The filtered crystals were washed with acetone and dried to give 7.5 g of D-(+ ephedrine D-(+)-dibenzoyl tartrate, mp: 172-173 °C.
2) 向步骤 1 回收的母液中加入 4.lg (O.Ollmol) D-(+)-二苯 甲酰基酒石酸, 在 50-60°C下, 加热搅拌使之完全溶解, 室温 (20°C)放置过夜, 过滤出晶体, 母液回收用于下一步实验。 过滤 出的晶体以丙酮洗涤, 干燥即得 0.82g D-(+麻黄碱 D-(+)-二苯甲 酰基酒石酸盐, mp: 171-172°C。 2) Add 4. lg (O.Ollmol) D-(+)-dibenzoyltartaric acid to the mother liquor recovered in step 1. Stir at 50-60 ° C with heating and stir at room temperature (20 ° C) Place overnight, filter out the crystals, and recover the mother liquor for the next experiment. The crystals which were filtered were washed with acetone and dried to give 0.82 g of D-(+ ephedrine D-(+)-dibenzoyl tartrate, mp: 171-172 °C.
3) 将 1和 2所得的 D-(+麻黄碱 D-(+)-二苯甲酰基酒石酸 盐合并共计 8.32g, 加入 30.0ml IN 的盐酸, 室温搅拌使之完全 溶解, 以 50.0ml 乙醚分两次提取, 分出乙醚层以回收拆分剂; 水层减压蒸去水得固体, 以无水乙醇重结晶, 过滤出晶体, 母液 保留用于回收 DL-麻黄碱。 过滤出的晶体以丙酮洗涤, 干燥即得 4.11g D-(+麻黄碱盐酸盐, 收率: 81.5%, mp: 218-220 °C, [a]D 20= -33.0。(5.1%,水); 1H-NMR(400MHz, CDC13): 69.04570 (brs, 2H), 7.41331-7.35334 (m, 4H), 7.29949-7.25677 (m, 1H), 6.14163 (d, 1H, J=4.424Hz), 5.19179 (dd, 1H, /!=4.220Hz, 2=2.672Hz), 3.33115(q, 1H, /=4.884Hz), 2.61525 (s, 3H), 0.92368 (d,3H, J=6.724Hz)。 3) Combine D-(+ ephedrine D-(+)-dibenzoyl tartrate obtained in 1 and 2 to a total of 8.32g, add 30.0ml of IN hydrochloric acid, stir at room temperature to completely dissolve, and divide with 50.0ml of ether. The mixture was extracted twice, and the ether layer was separated to recover the resolving agent; the aqueous layer was evaporated under reduced pressure to give a solid, which was recrystallized from anhydrous ethanol, and crystals were filtered, and the mother liquid was retained for recovery of DL-ephedrine. Wash with acetone and dry to give 4.11 g of D-(+ ephedrine hydrochloride, yield: 81.5%, mp: 218-220 °C, [a] D 20 = -33.0 (5.1%, water); 1 H -NMR (400MHz, CDC1 3 ): 69.04570 (brs, 2H), 7.41331-7.35334 (m, 4H), 7.29949-7.25677 (m, 1H), 6.14163 (d, 1H, J=4.424Hz), 5.19179 (dd, 1H, /!=4.220Hz, 2 = 2.672 Hz), 3.33115 (q, 1H, /=4.884 Hz), 2.61525 (s, 3H), 0.92368 (d, 3H, J = 6.724 Hz).
4) 将步骤 2的母液减压蒸去水和甲醇得稠状物, 向其中加 入 50.0ml 甲苯, 加热回流 4 小时, 冷却后过滤出固体, 母液回 收用于下步实验; 固体以丙酮洗涤, 干燥得 7.02g L-(+)麻黄碱 D-(+)-二苯甲酰基酒石酸盐, mp: 168-170。C。  4) The mother liquid of the step 2 was evaporated under reduced pressure to remove water and methanol to obtain a thick material. 50.0 ml of toluene was added thereto, and the mixture was heated under reflux for 4 hours. After cooling, the solid was filtered, and the mother liquid was recovered for the next step; the solid was washed with acetone. Drying gave 7.02 g of L-(+) ephedrine D-(+)-dibenzoyl tartrate, mp: 168-170. C.
5) 将步骤 4 中所得到的固体 L-(+)麻黄碱 D-(+)-二苯甲酰 基酒石酸盐 7.02g加入到 30ml IN 的盐酸中, 室温搅拌使之完 全溶解, 以 50.0ml 乙醚分两次提取, 分出乙醚层以回收拆分 剂; 水层减压蒸去水得固体, 以无水乙醇重结晶, 过滤出晶体, 母液保留用于回收 DL-麻黄碱。 过滤出的晶体以丙酮洗涤, 干燥 即得 3.66g L-(+)-麻黄碱盐酸盐, mp: 218-220 °C。  5) Add 7.02g of solid L-(+) ephedrine D-(+)-dibenzoyl tartrate obtained in step 4 to 30ml of IN hydrochloric acid, stir at room temperature to completely dissolve, to 50.0ml of ether. The extract was extracted twice, and the ether layer was separated to recover the resolving agent; the aqueous layer was evaporated under reduced pressure to give a solid, which was recrystallized from anhydrous ethanol, and crystals were filtered, and the mother liquid was retained for recovery of DL-ephedrine. The crystals which were filtered were washed with acetone and dried to give 3.66 g of L-(+)-ephedrine hydrochloride, mp: 218-220 °C.
6) 向步骤 4 回收的母液(甲苯层) 加入 15ml IN 的盐 酸, 充分搅拌后分出水层, 甲苯层保留以回收拆分剂; 水层减压 蒸去水得固体, 以无水乙醇重结晶, 过滤出晶体, 母液保留用于 回收 DL-麻黄碱。 过滤出的晶体以丙酮洗涤, 干燥即得 0.21g L- (+)-麻黄碱盐酸盐, mp: 219-221°C:。 将步骤 5)和步骤 6)所得的 L- (+)-麻黄碱盐酸盐合并得 3.87g, 收率: 76.8%, [a]D 20= +33.4°(5.1%,水); 1H-NMR(400MHz, CDC13): 68.9835 (brs, 2H), 7.4041-7.3543 (m, 4H), 7.3016-7.2649 (m, 1H), 6.1372 (d, 1H,
Figure imgf000013_0001
3.3400 (q, 1H, =4.66Hz), 2.6137(s, 3H), 0.9192 (d, 3H, /=6.72Hz)。
6) Add the 15 ml of IN hydrochloric acid to the mother liquor (toluene layer) recovered in step 4. After thoroughly stirring, the aqueous layer is separated, and the toluene layer is retained to recover the resolving agent. The aqueous layer is evaporated under reduced pressure to obtain a solid, which is recrystallized from absolute ethanol. The crystals are filtered out and the mother liquor is retained for recovery of DL-ephedrine. The crystals which were filtered were washed with acetone and dried to give 0.21 g of L-(+)-ephedrine hydrochloride, mp: 219-221 °C:. The L-(+)-ephedrine hydrochloride salt obtained in the step 5) and the step 6) was combined to obtain 3.87 g, yield: 76.8%, [a] D 20 = +33.4 ° (5.1%, water); 1 H -NMR (400MHz, CDC1 3 ): 68.9835 (brs, 2H), 7.4041-7.3543 (m, 4H), 7.3016-7.2649 (m, 1H), 6.1372 (d, 1H,
Figure imgf000013_0001
3.3400 (q, 1H, =4.66Hz), 2.6137(s, 3H), 0.9192 (d, 3H, /=6.72Hz).
7) 将步骤 3和步骤 5所得的乙醚层合并, 蒸馏回收乙醚, 然后向残留物中加入步骤 6)所得的甲苯层, 蒸馏回收大部分甲 苯, 得 7.9g 固体, 此即为回收的拆分剂 D- (+)-二苯甲酰基酒石 酸, 回收率: 83.8%, mp: 141-142。C, [a]D 20= -114·4。(5·0%,甲 醇)。 将步骤 3、 步骤 5和步骤 6以乙醇重结晶的母液合并, 蒸馏 以回收乙醇并得到 0.7 固体, 此为没有拆分开的 DL-麻黄碱盐 酸盐。 7) The diethyl ether layers obtained in the steps 3 and 5 are combined, and the diethyl ether is distilled off. Then, the toluene layer obtained in the step 6) is added to the residue, and most of the toluene is distilled off to obtain 7.9 g of a solid, which is a recovered split. D-(+)-dibenzoyltartaric acid, recovery: 83.8%, mp: 141-142. C, [a] D 20 = -114·4. (5.0%, methanol). The mother liquors which were recrystallized from ethanol in steps 3 , 5 and 6 were combined and distilled to recover ethanol and obtained 0.7 solids, which was DL-ephedrine hydrochloride which was not separated.

Claims

权 利 要 求 Rights request
1. 式 (I) 所示的 D-(+)-或 L- (-) -酒石酸衍生物作为 DL-麻黄 碱或其衍生物的拆分剂:  1. A D-(+)- or L-(-)-tartaric acid derivative represented by the formula (I) as a resolving agent for DL-ephedrine or a derivative thereof:
Figure imgf000015_0001
Figure imgf000015_0001
其中, 取代基 R各自独立地为 H、 CH3、 Cl F和 NO:Wherein the substituents R are each independently H, CH 3 , Cl F and NO:
2. 权利要求 1所述的拆分剂, 其中的 DL-麻黄碱或其衍生物 为式(II) DL-麻黄碱或其衍生物: The resolving agent according to claim 1, wherein the DL-ephedrine or a derivative thereof is the DL-ephedrine of the formula (II) or a derivative thereof:
Figure imgf000015_0002
Figure imgf000015_0002
其中, 、 R2 各自独立地为 H、 d~C5 的直链或支链烷 基, R3、 R4为 H、 OH、 卤素、 N02或 ~C3 直链或支链烷 基、 ~C3 直链或支链烷氧基。 Wherein, R 2 are each independently a linear or branched alkyl group of H, d~C 5 , and R 3 and R 4 are H, OH, halogen, N0 2 or ~C 3 straight or branched alkyl, ~C 3 straight or branched alkoxy.
3. 权利要求 1所述的拆分剂, 其中的 DL-麻黄碱或其衍生物 为式(III) DL-伪麻黄碱或其衍生物:
Figure imgf000016_0001
3. The resolving agent according to claim 1, wherein the DL-ephedrine or a derivative thereof is the DL-pseudoephedrine of the formula (III) or a derivative thereof:
Figure imgf000016_0001
(III)  (III)
其中, I 、 R2, 各自独立地为 H、 d~C5 的直链或支链烷 基, R3,、 R4,为 H、 OH、 卤素、 ]\02或 ~C3 直链或支链烷 基、 C^ C^ 直链或支链烷氧基。 Wherein I, R 2 are each independently a linear or branched alkyl group of H, d~C 5 , and R 3 , R 4 are H, OH, halogen, ]\0 2 or ~C 3 straight chain Or a branched alkyl group, a C^C^ linear or branched alkoxy group.
4. . 权利要求 1所述的拆分剂, 其中的 D-(+)-或 L-(- )-酒石酸 衍生物为具有式 (IV) 的 D-(+)-或 L- (-) -二苯甲酰基酒石酸: The resolving agent according to claim 1, wherein the D-(+)- or L-(-)-tartaric acid derivative is D-(+)- or L-(-) having the formula (IV). -Dibenzoyltartaric acid:
Figure imgf000016_0002
Figure imgf000016_0002
5. 权利要求 4所述的拆分剂, 其中的 DL-麻黄碱或其衍生物 为式 (II) DL-麻黄碱或其^"生物: The resolving agent according to claim 4, wherein the DL-ephedrine or a derivative thereof is a compound of the formula (II) DL-ephedrine or a compound thereof:
Figure imgf000016_0003
Figure imgf000016_0003
(II) 其中, 、 R2 各自独立地为 H、 d~C5 的直链或支链烷 基, R3、 R4为 H、 OH、 卤素、 N02或 C^Cs 直链或支链烷 基、 ~C3 直链或支链烷氧基。 (II) wherein, R 2 is independently a linear or branched alkane of H, d to C 5 The group, R 3 and R 4 are H, OH, halogen, N0 2 or C^Cs straight or branched alkyl, ~C 3 straight or branched alkoxy.
6. 权利要求 4所述的拆分剂, 其中的 DL-麻黄碱或其衍生物 为式(III) DL-伪麻黄碱或其衍生物: The resolving agent according to claim 4, wherein the DL-ephedrine or a derivative thereof is the DL-pseudoephedrine of the formula (III) or a derivative thereof:
Figure imgf000017_0001
Figure imgf000017_0001
其中, ,、 R2,各自独立地为 H、 d~C5 的直链或支链燒 基, R3,、 R4,为 H、 OH、 卤素、 N02或 d~C3 直链或支链綻 基、 直链或支链烷氧基。 Wherein, R 2 are each independently a linear or branched alkyl group of H, d~C 5 , and R 3 , R 4 are H, OH, halogen, N0 2 or d~C 3 straight chain or Branched radical, linear or branched alkoxy.
7. 应用式 (I) D-(+)-或 L-(+酒石酸衍生物拆分 DL- 或其衍生物的方法, 7. A method of using the formula (I) D-(+)- or L-(+ tartaric acid derivative to resolve DL- or a derivative thereof,
Figure imgf000017_0002
Figure imgf000017_0002
(I) 其中, 取代基 R各自独立地为 H、 CH3、 Cl、 F和 Ν02, 该方法包括使式 (I) 所示的 D-(+)-或 L- (-) -酒石酸衍生物与 式 (II) DL-麻黄碱或其衍生物或式 (III) DL-伪麻黄碱或其衍 生物以一定的摩尔比接触,
Figure imgf000018_0001
(I) wherein the substituents R are each independently H, CH 3 , Cl, F and Ν0 2 , the method comprising deriving D-(+)- or L-(-)-tartaric acid represented by formula (I) And the DL-ephedrine or a derivative thereof or the formula (III) DL-pseudoephedrine or a derivative thereof is contacted at a certain molar ratio,
Figure imgf000018_0001
(II) (III) 其中, 在式 (II) 中, 、 R2 各自独立地为 H、 Ci~C5 直 链或支链烷基, R3、 R4为 H、 OH、 卤素、 N02或 d~C3 直链 或支链烷基、 d~C3 直链或支链烷氧基, (II) (III) wherein, in the formula (II), R 2 is each independently H, Ci~C 5 linear or branched alkyl, and R 3 and R 4 are H, OH, halogen, N0 2 Or a d-C 3 linear or branched alkyl group, a d-C 3 straight or branched alkoxy group,
在式(III) 中 ,、 R2, 各自独立地为 H、 d~C5 直链或支 链烷基, R3,、 R4,为 H、 OH、 卤素、 N02或 d~C3 直链或支 链烷基、 d~C3 直链或支链烷氧基, In formula (III), R 2 is independently H, d~C 5 straight or branched alkyl, R 3 , R 4 is H, OH, halogen, N0 2 or d~C 3 a linear or branched alkyl group, a d~C 3 straight or branched alkoxy group,
并经过常规处理和随后的酸化处理, 得到光学活性麻黄碱或 其衍生物异构体。  The optically active ephedrine or derivative isomer thereof is obtained by conventional treatment and subsequent acidification.
8. 权利要求 7所述的方法, 该方法包括以下步骤: 8. The method of claim 7 comprising the steps of:
1) 使权利要求 7 中式 (II) 或式 (ΠΙ) 所示化合物与式 (I) D-(+)-或 L- (-) -酒石酸或其衍生物以 1:0.1 ~ 1:1.2 的摩尔比 混合, 经常规处理, 相应得到 D- (-)麻黄碱或其衍生物 二 苯甲酰基酒石酸衍生物盐或 L-(+)麻黄碱或其衍生物 L-(-)-二苯 甲酰基酒石酸衍生物盐晶体;  1) The compound of the formula (II) or the formula (ΠΙ) of claim 7 and the D-(+)- or L-(-)-tartaric acid or a derivative thereof of the formula (I) are from 1:0.1 to 1:1.2. The molar ratio is mixed, and conventionally obtained, correspondingly obtained D-(-) ephedrine or its derivative dibenzoyl tartaric acid derivative salt or L-(+) ephedrine or its derivative L-(-)-diphenyl Acyl tartaric acid derivative salt crystal;
2) 步骤 1) 所得晶体经酸化处理, 得到 D- (-)麻黄碱或其衍 生物盐酸盐或 L-(+)麻黄碱或其衍生物盐酸盐;  2) Step 1) The obtained crystal is acidified to obtain D-(-) ephedrine or its derivative hydrochloride or L-(+) ephedrine or its derivative hydrochloride;
为了得到另一种光学活性异构体,  In order to obtain another optically active isomer,
3) 将步骤 1) 的母液减压蒸去水和醇得稠状物, 向其中加 入甲苯, 加热回流, 经常规处理后得到 L-(+)麻黄碱或其衍生物 D-(+)-二苯甲酰基酒石酸衍生物盐晶体或 D-(-)麻黄碱或其衍生物 L-(+二苯甲酰基酒石酸衍生物盐晶体; 4 ) 步骤 3 ) 所得晶体经酸化处理, 得到 L-(+)麻黄碱或其衍 生物盐酸盐或 D+)麻黄碱或其衍生物盐酸盐。 3) The mother liquid of step 1) is evaporated under reduced pressure to remove water and alcohol to obtain a thick substance, toluene is added thereto, and the mixture is heated under reflux to obtain L-(+) ephedrine or its derivative D-(+)- after conventional treatment. a dibenzoyl tartaric acid derivative salt crystal or D-(-) ephedrine or a derivative thereof L-(+ dibenzoyl tartaric acid derivative salt crystal; 4) Step 3) The obtained crystal is acidified to obtain L-(+) ephedrine or its derivative hydrochloride or D+) ephedrine or its derivative hydrochloride.
9. 权利要求 8所述的方法, 其中可以向步骤 1 ) 的母液中再 次加入拆分剂式 (I ) D-(+)-或 L- (-) -酒石酸衍生物, 常规处理后 进一步得到 D-(-)麻黄碱或其衍生物 D-(+)-二苯甲酰基酒石酸衍 生物盐或 L-(+)麻黄碱或其衍生物 L-(-)-二苯甲酰基酒石酸衍生 物盐。 9. The method according to claim 8, wherein a resolving agent of the formula (I) D-(+)- or L-(-)-tartaric acid derivative can be further added to the mother liquor of the step 1), which is further obtained after conventional treatment. D-(-) ephedrine or a derivative thereof D-(+)-dibenzoyltartaric acid derivative salt or L-(+) ephedrine or a derivative thereof L-(-)-dibenzoyltartaric acid derivative salt.
10. D-(+)-或 L-(-)-酒石酸衍生物拆分剂的回收方法, 该方法 包括将权利要求 8步骤 2 )和 4 ) 酸化处理过程中分出的有机层 蒸馏, 回收溶剂后得到拆分剂 D-(+)-或 L-(- )-酒石酸衍生物。 10. A method for recovering a D-(+)- or L-(-)-tartaric acid derivative resolving agent, which comprises distilling the organic layer separated in the acidification treatment of step 8 of claim 8 and 4) The solvent D-(+)- or L-(-)-tartaric acid derivative is obtained after the solvent.
PCT/CN2004/001338 2004-11-23 2004-11-23 The process for resolving dl-epherine, pseudoephedrine or the derivatives thereof and the resolving agents WO2006056098A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2004/001338 WO2006056098A1 (en) 2004-11-23 2004-11-23 The process for resolving dl-epherine, pseudoephedrine or the derivatives thereof and the resolving agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2004/001338 WO2006056098A1 (en) 2004-11-23 2004-11-23 The process for resolving dl-epherine, pseudoephedrine or the derivatives thereof and the resolving agents

Publications (1)

Publication Number Publication Date
WO2006056098A1 true WO2006056098A1 (en) 2006-06-01

Family

ID=36497720

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2004/001338 WO2006056098A1 (en) 2004-11-23 2004-11-23 The process for resolving dl-epherine, pseudoephedrine or the derivatives thereof and the resolving agents

Country Status (1)

Country Link
WO (1) WO2006056098A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110455849A (en) * 2019-08-07 2019-11-15 上海市刑事科学技术研究院 The quick Testing and appraisal method of ephedrine and pseudoephedrine based on NMR

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB405520A (en) * 1932-06-11 1934-02-08 Helmut Legerlotz A process for reversing the rotation of optically active phenyl alkamines
JPH07138206A (en) * 1993-11-19 1995-05-30 Toray Ind Inc Production of o, o'-diacyltartaric acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB405520A (en) * 1932-06-11 1934-02-08 Helmut Legerlotz A process for reversing the rotation of optically active phenyl alkamines
JPH07138206A (en) * 1993-11-19 1995-05-30 Toray Ind Inc Production of o, o'-diacyltartaric acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LIHONG G ET AL: "Resolution of DL-pseudoephedrine by supercritical fluid extraction", ACTA PHARMACEUTICA SINICA, vol. 37, no. 12, 2002, pages 959 - 962 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110455849A (en) * 2019-08-07 2019-11-15 上海市刑事科学技术研究院 The quick Testing and appraisal method of ephedrine and pseudoephedrine based on NMR

Similar Documents

Publication Publication Date Title
JP2000517288A (en) Optical Resolution of Methylphenidate by O, O&#39;-Bisaroyl Tartaric Acids
JPH11193270A (en) Production of optically active 1-methyl-3-piperidinemethanol
WO2009062377A1 (en) Resolution of 4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane
JPH10507464A (en) Crystallization of levobupivacaine and its analogs
GB2348202A (en) Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino-9H-purin-9-yl]- 2-cyclopentene-1-methanol
KR20010112223A (en) Process for the Resolution of Tramadol
AU2002229575B2 (en) A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid
WO2006056098A1 (en) The process for resolving dl-epherine, pseudoephedrine or the derivatives thereof and the resolving agents
JP3135696B2 (en) Optical resolution method of 2- (4-isobutylphenyl) propionic acid
JP2004511476A (en) Method for producing R (+) α-lipoic acid
JP3088777B2 (en) Novel optical resolving agent and method for producing optically active amine using the same
WO2005118524A1 (en) Process for preparing [(s)-(-)alpha-methylamino phenylacetone]2 (2r, 3r)-tartaric acid derivates
US20070112074A1 (en) Tramadol recovery process
WO2006050633A1 (en) The process for resolving dl-ephedrine or the derivatives thereof and the resolving agents
MXPA01013145A (en) Method for separating the diastereomer bases of 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol.
CN100475774C (en) D-(+) or L-(-)- tartaric acid or derivative as resolving agent for ephedrine or ramification and resolving method
JP2007513936A (en) Method for the division of nefopam
JP6670744B2 (en) Polymorphic forms of sodium hyodeoxycholate (NaHDC) and methods for their preparation
JPS6139299B2 (en)
JP3316917B2 (en) New phenylalanine salt crystals and their production
JP2917464B2 (en) Preparation of optically active 1-methyl-3-phenylpropylamine
WO1990008126A1 (en) Resolution process
JP2574254B2 (en) Optical resolution method
JP3284607B2 (en) Method for producing optically active 1-phenylethylamine
WO2001017944A1 (en) Process for producing optically active aminoalcohol

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 04797369

Country of ref document: EP

Kind code of ref document: A1